News On Japan

New Innovations in Painless Injections

TOKYO, Nov 18 (News On Japan) - Many people, especially children, dread injections. However, companies in the Kansai region are advancing the development of 'painless injections,' utilizing innovative technologies.

These breakthroughs aim to reduce stress during medical treatments and are even showing potential in the beauty industry. The latest advancements include adhesive injections already in use in some dental clinics and needle-free gas injections under development.

The pursuit of pain-free injections has been ongoing for years. For example, 10 years ago, researchers designed a mosquito-inspired needle, mimicking the insect's painless bite. However, high costs prevented it from becoming a practical solution.

Currently, various companies are focusing on adhesive injections. A dental clinic in Kyoto employs these for procedures involving pain. This technology uses a patch covered with more than 1,000 micro-needles per square centimeter. The microscopic needles, containing medication at their tips, penetrate the skin and deliver the medicine directly into capillaries, spreading throughout the body. Thanks to advancements in nanotechnology, these micro-needles are now easier and more cost-effective to produce.

In dental settings, micro-needles are coated with anesthetics to alleviate pain during procedures. While the drug delivery capacity of these patches is limited compared to traditional injections, they are highly effective for pre-anesthetic applications. Patients report significantly reduced stress, and dental professionals find it easier to administer pain relief.

Micro-needle technology is also being explored in the beauty industry. A cream containing tiny amino-acid-based needles delivers cosmetic ingredients deep into the skin as the needles dissolve. This method allows for greater absorption and effectiveness compared to traditional creams or lotions.

Another promising innovation is the gas-powered injection device, developed by a manufacturer in Nara Prefecture. Instead of a needle, this device uses compressed carbon dioxide to propel medicine through a micro-opening just 0.18 mm wide, painlessly delivering it into the body. Made from eco-friendly materials like sugarcane, these devices are designed to be sustainable, with recyclable parts.

While the gas-powered injection device is still undergoing certification, it is expected to be commercialized within seven to eight years. Experts believe it could revolutionize vaccine administration, particularly during pandemics, enabling self-application with minimal stress.

As these advancements continue, the era of pain-free injections is drawing closer, with potential to transform both healthcare and beauty industries.

Source: YOMIURI

News On Japan
POPULAR NEWS

As the exchange of attacks between Israel and Iran continues, the evacuation of Japanese nationals from Israel has commenced.

Nippon Steel has completed its acquisition of US Steel, spending approximately 2 trillion yen over a period of 18 months. Speaking at a press conference the day after the announcement, Chairman Hashimoto emphasized that "profitability and management flexibility have been secured."

Japan Post is facing the suspension of approximately 2,500 trucks for five years after failing to appear at a hearing held by the Ministry of Land, Infrastructure, Transport and Tourism over improper safety checks on drivers. With no objection raised by Japan Post, the penalty is expected to be finalized as early as June.

An iron bridge in Kumatori, Osaka Prefecture, has been identified as Japan's oldest existing iron bridge, having been repurposed from a railway bridge constructed 150 years ago. The Omiyabashi bridge, which spans a river in Kumatori, was completed in 1931, measuring approximately 21 meters long and 6 meters wide.

Actress Kanako Kojima has suffered a serious facial injury after being bitten by a dog, requiring around 30 stitches.

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

The launch of the H2A rocket's final unit, originally scheduled for June 24th, has been postponed due to a malfunction in the rocket’s electrical system.

Honda has announced that it successfully completed a landing and takeoff experiment with a small rocket in Taiki Town, located in Hokkaido’s Tokachi region. This achievement marks the first time a Japanese private company has accomplished this feat.

A new ranking of 'technologies that are attracting investment' has just been published, with an analysis of some of the most promising innovations.

Masahiko Inami, professor and deputy director at the University of Tokyo’s Research Center for Advanced Science and Technology, is leading groundbreaking research into human augmentation—technology that expands human capabilities beyond natural limitations. Inspired by science fiction and driven by a vision of a more inclusive and creative future, Inami’s work aims not only to assist those with physical challenges but to elevate all individuals through the integration of new skills and sensory functions.

Japan’s bid for a successful private-sector moon landing has ended in failure for the second time, after startup ispace announced that it lost communication with its lunar lander Resilience during the final descent.

Kyoto University's Center for iPS Cell Research and Application (CiRA) and pharmaceutical company Towa announced they began the final phase of clinical trials in May, aiming to treat Alzheimer’s disease using an existing medication.

A Shizuoka Prefecture expert panel overseeing environmental issues linked to the Linear Chuo Shinkansen project met on June 2nd and concluded all discussions related to water resources, ending over a decade of debate. Deputy Governor Hiraki described the outcome as "a major step forward."

The Japan Aerospace Exploration Agency (JAXA) on June 2nd unveiled its new unmanned cargo spacecraft, the HTV-X, at the Tanegashima Space Center in Kagoshima Prefecture. Designed to transport supplies to the International Space Station (ISS), the HTV-X is undergoing final preparations for launch within fiscal 2025.